Background There is a lack of population-based information on the disease burden and management of alopecia areata. Objective To describe the epidemiology of alopecia areata, focusing on incidence, demographics, and patterns of healthcare utilisation. Methods Population-based cohort study of 4.16 million adults and children, using UK electronic primary care records from the Oxford-Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) network database, 2009-2018. Incidence and point prevalence of alopecia areata was estimated. Variation in alopecia areata incidence by age, sex, deprivation, geographical distribution and ethnicity was examined. Patterns of healthcare utilisation were evaluated in people with incident alopecia areata. Results Alopecia areata incidence was 0.26 per 1,000 person-years. Alopecia areata point prevalence in 2018 was 0.58% in adults. Alopecia areata onset peaked at age 25-29 for both sexes, although the peak was broader in females. People of non-white ethnicity were more likely to present with alopecia areata, especially those of Asian ethnicity (Incidence rate ratio 3.32 [95% confidence interval 3.11-3.55]). Higher alopecia areata incidence was associated with social deprivation (IRR most vs least deprived quintile 1.47 [1.37-1.59]) and urban-living (IRR 1.23 [1.14-1.32]). People of higher social deprivation were less likely to be referred for specialist dermatology review. Conclusion By providing the first large-scale estimates of the incidence and point prevalence of AA, our study helps to understand the burden of AA on the population. Understanding the variation in AA onset between different population groups may give insight into the pathogenesis of AA and its management.
Frontal fibrosing alopecia (FFA) is a recently described inflammatory and scarring type of hair loss affecting almost exclusively women. Despite a dramatic recent increase in incidence the aetiopathogenesis of FFA remains unknown. We undertake genome-wide association studies in females from a UK cohort, comprising 844 cases and 3,760 controls, a Spanish cohort of 172 cases and 385 controls, and perform statistical meta-analysis. We observe genome-wide significant association with FFA at four genomic loci: 2p22.2, 6p21.1, 8q24.22 and 15q2.1. Within the 6p21.1 locus, fine-mapping indicates that the association is driven by theHLA-B*07:02 allele. At 2p22.1, we implicate a putative causal missense variant inCYP1B1, encoding the homonymous xenobiotic- and hormone-processing enzyme. Transcriptomic analysis of affected scalp tissue highlights overrepresentation of transcripts encoding components of innate and adaptive immune response pathways. These findings provide insight into disease pathogenesis and characterise FFA as a genetically predisposed immuno-inflammatory disorder driven byHLA-B*07:02.